Last update 21 Nov 2024

Udenafil

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Udenafil (USAN/INN), Udzire, Zydena
+ [7]
Target
Mechanism
PDE5A inhibitors(Phosphodiesterase 5A inhibitors)
Originator Organization
Drug Highest PhaseApproved
First Approval Date
KR (29 Nov 2005),
RegulationOrphan Drug (EU)
Login to view timeline

Structure

Molecular FormulaC25H36N6O4S
InChIKeyIYFNEFQTYQPVOC-UHFFFAOYSA-N
CAS Registry268203-93-6

External Link

KEGGWikiATCDrug Bank
D10027Udenafil

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Erectile Dysfunction
KR
29 Nov 2005
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Alzheimer DiseasePreclinical
KR
01 Sep 2013
Heart failure with normal ejection fractionPreclinical
KR
01 Oct 2012
Heart Failure, DiastolicPreclinical
KR
01 Oct 2012
Idiopathic pulmonary arterial hypertensionPreclinical
KR
01 Sep 2012
Chronic systolic heart failurePreclinical
KR
01 Dec 2011
DyspneaPreclinical
KR
01 Mar 2010
Pulmonary Disease, Chronic ObstructivePreclinical
KR
01 Mar 2010
Hypertension, PulmonaryPreclinical
KR
-
Hypertension, PulmonaryPreclinical
KR
-
Erectile DysfunctionDiscovery
US
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
63
svwaqqxxhw(esindtdlud) = tvaostupew dmvsykyndm (djybfxliii )
-
01 Apr 2019
svwaqqxxhw(esindtdlud) = lyoulzqgyt dmvsykyndm (djybfxliii )
Phase 1
-
-
(Healthy young men (21-27 years))
(uvdxvorykv) = fpulvjbaou fcafhqborj (bsdnkipdnl )
-
01 Nov 2016
(Healthy elderly men (65-78 years))
(uvdxvorykv) = mbhjfnppum fcafhqborj (bsdnkipdnl )
Phase 2/3
12
gwufltiqak(zzxdxcudxz) = grdsuqbhlb dmednsfrft (lowfazxboe )
-
11 Jun 2014
Phase 3
23
(cenbinmvtm) = yikkhlqfpa esbilwfyzl (hdwnxekghl )
-
01 Aug 2012
Phase 3
618
(Udenafil 50 mg)
yvxlwlkksi(ctwlcdqajq) = ztibztvpgo xocrnhpphr (rqqkkydbtg, kdsibziute - lcfsgofrbj)
-
22 Dec 2011
(Udenafil 100 mg)
yvxlwlkksi(ctwlcdqajq) = astrvmmezv xocrnhpphr (rqqkkydbtg, rehlwpvyyh - mldcjgeykw)
Phase 3
601
Placebo+Udenafil
(Udenafil 50 mg)
yikhlqarbb(wiaelxssia) = ogfgmafuks rztdjfqubw (guiwjkiiof, wpyqciyyqc - evfbaltkwn)
-
22 Dec 2011
Placebo+Udenafil
(Udenafil 100 mg)
yikhlqarbb(wiaelxssia) = cgewnnysco rztdjfqubw (guiwjkiiof, bbctwhanrq - krcgwlwwbt)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free